Clinical Trial Update: XIENCE 28 USA Study [NA]

View source ↗

Summary

Clinical trial update for XIENCE 28 USA study has completed with results posted in December 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Bleeding Disorder
• Coagulation Disorder
• Coronary Artery Disease
• Hematological Diseases
• Hemorrhagic Stroke
• Renal Insufficiency
• Stroke
• Thrombocytopenia

Drugs mentioned

• Xience (everolimus-eluting stent with permanent polymer)

Snippet

Sponsor: Abbott Medical Devices | Conditions: Bleeding Disorder, Ischemic Stroke | NA | Status: COMPLETED | Results posted: 2021-12-14